Moscow began distributing the Sputnik V Covid-19 shot via 70 clinics on Dec. 5 to the most exposed groups, marking Russia’s first large-scale vaccination against the disease, the city’s coronavirus task force said.
Coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for Covid-19 shots, with a reported $40 per dose price tag the “highest number” in that range, one of the co-leads of the project said.
Blackstone Life Sciences V fund closed at its hard cap of $4.6 billion of total capital commitments, marking the largest life sciences private fund that raised to date.
With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate NVX‑CoV2373.
The U.S. Supreme Court ruled that a 2003 law does not violate constitutional free speech rights by requiring overseas affiliates of American-based nonprofit groups that seek federal funding for HIV/AIDS relief to take a formal stance opposing prostitution and sex trafficking.
Glass maker Corning will receive $204 million from the U.S. government to boost the manufacturing capacity of vials that will be used to store coronavirus vaccines and treatments.
Biotech investor Atlas Venture has a new fund that will support the launch of startups in the industry.
After multiple failures to develop therapeutics for Alzheimer’s disease, Biogen’s Michael D. Ehlers resigned from his role as head of research and development.
Four months after securing $125 million in funding, SpringWorks Therapeutics is eying another $115 million from a potential initial public offering.
Israeli biopharma firm BiomX raised $32 million in a private funding round that will primarily be used to advance the company’s drug candidates for the treatment of acne and inflammatory bowel disease (IBD).